Skip to content

Clinical trials

Phase 1/2 Myelodysplastic Syndromes trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 1/2 Country / region: France Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20091
20103
20112
20133
20141
20164
20202
20213
20223
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting4
Terminated4
Suspended1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Groupe Francophone des Myelodysplasies9
Incyte Corporation2
Advanced BioDesign1
BeOne Medicines1
Celgene1
Constellation Pharmaceuticals1
Curis, Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
Forma Therapeutics, Inc.1
Institut Paoli-Calmettes1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes26
Leukemia, Myeloid, Acute14
Multiple Myeloma4
Leukemia3
Leukemia, Myelomonocytic, Chronic3
Recurrence3
Bone Marrow Diseases2
Colorectal Neoplasms2
Myelodysplastic-Myeloproliferative Diseases2
Myeloproliferative Disorders2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.